Orthotopic studies showed that combinatorial BCL‐XL+WEE1 inhibition reduced in vivo tumor growth of MGT11Luc cells injected into the mammary fat pad of mice (Figure 5f–i; Figure S5g, Supporting Information). Here, BCL2L1 is linked to neoplasm.